The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Chronic pain affects approximately 1 in 5 Americans, and yet it remains one of the most misunderstood and challenging medical ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...